Integrin beta 1 Binding Protein 3 (ITGB1BP3) (Middle Region) Peptid
ITGB1BP3
Reaktivität: Human
Wirt: Synthetic
BP, WB
Produktnummer ABIN978660
150,78 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach:
Deutschland
Lieferung in 15 bis 22 Werktagen
Kurzübersicht für Integrin beta 1 Binding Protein 3 (ITGB1BP3) (Middle Region) Peptid (ABIN978660)
Target
ITGB1BP3
(Integrin beta 1 Binding Protein 3 (ITGB1BP3))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-ITGB1BP3 antibody (Catalog #: ARP42714_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Aufreinigung
- Purified
-
-
-
-
Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Konzentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- ITGB1BP3 (Integrin beta 1 Binding Protein 3 (ITGB1BP3))
-
Hintergrund
-
ITGB1BP3 catalyzes the phosphorylation of nicotinamide riboside (NR) and nicotinic acid riboside (NaR) to form nicotinamide mononucleotide (NMN) and nicotinic acid mononucleotide (NaMN).ITGB1BP3 reduces laminin matrix deposition and cell adhesion to lami
Alias Symbols: MGC126624, MIBP, NRK2, ITGB1BP3
Protein Interaction Partner: CDKN1A,ITGB1,LRP12,SAT1,SAT1,ST7
Protein Size: 230 -
Molekulargewicht
- 26 kDa
-
Gen-ID
- 27231
-
NCBI Accession
- NM_170678, NP_733778
-
UniProt
- Q9NPI5
Target
-
Sie sind hier:
